OBP was corporatised in the year 2000 under the Onderstepoort Biological Products Incorporation Act, 1999 *Act of 1999). The objective of the corporatisation was to create an environment that is favourable for the organisation to build capacity in manufacturing technologies, infrastructure and the development of new products; the critical success factors for financial viability and sustainability. Over the past 10 years, OBP has performed very well and continued to play an important role in the prevention and control of animal diseases in South Africa, Africa and the world. In 2009, the organisation developed a 3-year strategic plan ( OBP Strategic Plan 2009-2013) that defined the Vision, Mission and Mandate.
To be a global biotech manufacturer and provider of animal health products underpinned by a skilled, innovative and passionate team.
To translate science into biological product, knowledge and technology resulting in improved animal and human health, food security and safety for all stakeholder.
OBP exists to prevent and control animal diseases that impact food security, human health and livelihood.